Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry

As compared with MCS, patients with FCS showed a more severe phenotype and higher prevalence of <i>LPL</i> variants. Lomitapide and volanesorsen provide better triglyceride control, yet only one-third of FCS were treated with these drugs in the routine clinical practice.

Authors

Institutions

Publication Details

Journal
Arteriosclerosis Thrombosis and Vascular Biology
Published
2025-10-16
DOI
https://doi.org/10.1161/atvbaha.125.323340
Citations
3
Primary Topic
Lipid metabolism and disorders
Type
article
Field-Weighted Citation Impact
4.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry

Matteo Pirro, Giulia Fainelli, Francesco Baratta, Giuliana Mombelli et al.
3 citations
Arteriosclerosis Thrombosis and Vascular Biology
Lipid metabolism and disorders
4.16
article

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry

Matteo Pirro, Giulia Fainelli, Francesco Baratta, Giuliana Mombelli, S. Calandra, Sabina Zambon, Matteo Nicola Dario Di Minno, Andrea Bartuli, Luigi Rizzi, Sergio D’Addato, Federica Galimberti, Manuela Casula, Patrizia Tarugi, Marta Biolo, Salvatore Piro, Gabriella Iannuzzo, Chiara Pavanello, Arianna Toscano, Tiziana Montalcini, Angelo B. Cefalù, Alessia Di Costanzo, Maria Grazia Zenti, Fabio Nascimbeni, Fabio Pellegatta, Maria Donata Di Taranto, Cristina Pederiva, Roberto Scicali, Guglielmo Beccuti, Simone Bini, Paola Sabrina Buonuomo, Simonetta Lugari, Arturo Pujia, Maurizio Averna, Andrea Silvio Benso, Antonina Giammanco, Alberto Zambon, Marcello Arca, Vanessa Bianconi, Daniele Tramontano, Giuseppe Mandraffino, Laura D’Erasmo, Patrizia Suppressa, Ilenia Minicocci, Francesco Sbrana, Alberico L. Catapano, Juliana Lago, Davide Noto, Liliana Grigore, Giuseppe Banderali, Beatrice Dal Pino, Fortunato Giuliana
article en
3 citations

Abstract

As compared with MCS, patients with FCS showed a more severe phenotype and higher prevalence of <i>LPL</i> variants. Lomitapide and volanesorsen provide better triglyceride control, yet only one-third of FCS were treated with these drugs in the routine clinical practice.

Arteriosclerosis Thrombosis and Vascular BiologyVol. 45(12)
University of Modena and Reggio Emilia (IT), University of Padua (IT), University of Milan (IT), Policlinico Umberto I (IT), MultiMedica (IT), Department of Health (ES), Instituto di Biofisica (ES), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 5%
Lipid metabolism and disorders
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.